Literature DB >> 15788957

Understanding neuropathic pain.

Walter Zieglgänsberger1, Achim Berthele, Thomas R Tölle.   

Abstract

Neuropathic pain is defined as a chronic pain condition that occurs or persists after a primary lesion or dysfunction of the peripheral or central nervous system. Traumatic injury of peripheral nerves also increases the excitability of nociceptors in and around nerve trunks and involves components released from nerve terminals (neurogenic inflammation) and immunological and vascular components from cells resident within or recruited into the affected area. Action potentials generated in nociceptors and injured nerve fibers release excitatory neurotransmitters at their synaptic terminals such as L-glutamate and substance P and trigger cellular events in the central nervous system that extend over different time frames. Short-term alterations of neuronal excitability, reflected for example in rapid changes of neuronal discharge activity, are sensitive to conventional analgesics, and do not commonly involve alterations in activity-dependent gene expression. Novel compounds and new regimens for drug treatment to influence activity-dependent long-term changes in pain transducing and suppressive systems (pain matrix) are emerging.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15788957     DOI: 10.1017/s1092852900022628

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  13 in total

1.  [Trigger points - Diagnosis and treatment concepts with special reference to extracorporeal shockwaves].

Authors:  M Gleitz; K Hornig
Journal:  Orthopade       Date:  2012-02       Impact factor: 1.087

2.  Dermatomal laser-evoked potentials: a diagnostic approach to the dorsal root. Norm data in healthy volunteers and changes in patients with radiculopathy.

Authors:  Markus Quante; Michael Hauck; Melanie Gromoll; Ekkehard Hille; Jürgen Lorenz
Journal:  Eur Spine J       Date:  2006-11-14       Impact factor: 3.134

Review 3.  Painful diabetic neuropathy is more than pain alone: examining the role of anxiety and depression as mediators and complicators.

Authors:  Rakesh Jain; Shailesh Jain; Charles L Raison; Vladimir Maletic
Journal:  Curr Diab Rep       Date:  2011-08       Impact factor: 4.810

Review 4.  Chronic Pain and the Endocannabinoid System: Smart Lipids - A Novel Therapeutic Option?

Authors:  Walter Zieglgänsberger; Rudolf Brenneisen; Achim Berthele; Carsten T Wotjak; Borwin Bandelow; Thomas R Tölle; Beat Lutz
Journal:  Med Cannabis Cannabinoids       Date:  2022-03-22

5.  A systematic comparison between subjects with no pain and pain associated with active myofascial trigger points.

Authors:  Lynn H Gerber; Siddhartha Sikdar; Katee Armstrong; Guoqing Diao; Juliana Heimur; John Kopecky; Diego Turo; Paul Otto; Tadesse Gebreab; Jay Shah
Journal:  PM R       Date:  2013-06-28       Impact factor: 2.298

6.  [Risk assessment in pain therapy].

Authors:  D Schoeffel; H R Casser; M Bach; H G Kress; R Likar; H Locher; W Steinleitner; M Strohmeier; H Brunner; R D Treede; W Zieglgänsberger; J Sandkühler
Journal:  Schmerz       Date:  2008-10       Impact factor: 1.107

Review 7.  [Neuropathic pain. How to open the blackbox].

Authors:  C Maier; R Baron; C Sommer
Journal:  Schmerz       Date:  2015-10       Impact factor: 1.107

8.  [Pain and consciousness. Articles from the summer workshop held by the German Interdisciplinary Collaboration for Pain Therapy (DIVS) in 2005].

Authors:  H Laubenthal; M Valet; T Sprenger; A Wöller; T R Tölle; H Röpcke; S Wirz; C Schröter; M Schiltenwolf; P Henningsen; T Sundermeier; H J Ebell; N Kohnen; W Häuser
Journal:  Schmerz       Date:  2007-06       Impact factor: 1.107

Review 9.  Botulinum Toxin for Neuropathic Pain: A Review of the Literature.

Authors:  Hyun-Mi Oh; Myung Eun Chung
Journal:  Toxins (Basel)       Date:  2015-08-14       Impact factor: 4.546

10.  Effect of chronic pain on fentanyl self-administration in mice.

Authors:  Carrie L Wade; Perry Krumenacher; Kelley F Kitto; Cristina D Peterson; George L Wilcox; Carolyn A Fairbanks
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.